• Norovirus Selective Protein Secretion via NINJ1 and Caspase-

  2026-06-24

  This study uncovers how murine norovirus (MNoV) exploits the host protein NINJ1 to enable selective secretion of its intracellular NS1 protein, independent of conventional secretion pathways. The findings reveal a specific, caspase-3-dependent mechanism that coordinates viral evasion of host immunity and controlled plasma membrane rupture, advancing our understanding of virus-host interactions and regulated cell death.

• CUDC-907: Protocol and QC Guidance for Dual PI3K/HDAC Inhibi

  2026-06-23

  CUDC-907 addresses the need for precise, simultaneous inhibition of PI3K/AKT and HDAC pathways in cancer cell research. It is best suited for controlled in vitro workflows focused on cell signaling, cycle, and apoptosis modulation, and should not be used for diagnostic, therapeutic, or clinical applications.

• siRNA Nanoparticles Target TDRD9 to Alleviate P. aeruginosa

  2026-06-23

  This study demonstrates that hyaluronic acid-coated siRNA nanoparticles targeting TDRD9 induce neutrophil cuproptosis, significantly reducing lung injury in preclinical Pseudomonas aeruginosa models. The findings reveal a previously uncharacterized immune modulation mechanism and establish a foundation for nanoparticle-mediated therapies in multidrug-resistant bacterial pneumonia.

• HMGB1 as an Early Serum Biomarker for Diabetic Nephropathy

  2026-06-22

  This study identifies HMGB1 as a promising serum biomarker for early detection and monitoring of diabetic nephropathy, using advanced quantitative proteomics and rigorous experimental validation. The findings highlight HMGB1's superior sensitivity compared to conventional diagnostic markers, potentially transforming noninvasive DN screening strategies.

• Fluorescein TSA Fluorescence System Kit for Ultra-Sensitive

  2026-06-22

  Harness ultrasensitive amplification for immunohistochemistry, immunocytochemistry, and in situ hybridization with the Fluorescein TSA Fluorescence System Kit. This APExBIO solution empowers researchers to visualize low-abundance targets with unmatched clarity, as demonstrated in advanced nephrology models and spatial omics workflows.

• Angiotensin III: Experimental Workflows and Troubleshooting

  2026-06-21

  Angiotensin III (human, mouse) stands out as a precision tool for dissecting RAAS function and receptor signaling, thanks to its robust quality control and validated bioactivity. This guide delivers actionable protocol upgrades, advanced applications, and troubleshooting insights for cardiovascular and neuroendocrine research, leveraging recent mechanistic findings and APExBIO’s highly pure peptide.

• BMS-345541 (free base): Reliable IKK Inhibition for Cell Ass

  2026-06-20

  BMS-345541 (free base) (SKU B4655) offers bench scientists a proven, selective IKK-1/IKK-2 inhibitor for robust NF-κB pathway interrogation in inflammation, cancer, and angiogenesis models. This scenario-driven guide addresses practical challenges in viability, cytokine, and apoptosis assays, illustrating how BMS-345541 (free base) ensures reliable, reproducible data across workflows.

• Enhancing mRNA Synthesis: Scenario-Driven Insights with Pseu

  2026-06-19

  This article delivers authoritative, scenario-driven guidance for biomedical researchers seeking robust solutions in RNA stability and mRNA synthesis with pseudouridine modification. Drawing on real laboratory challenges, it demonstrates how 'Pseudo-UTP' (SKU B7972) enables reproducible, high-yield RNA workflows and supports advanced applications such as mRNA vaccine development. Evidence-based answers and protocol parameters are provided to empower confident adoption of this modified nucleotide.

• Vancomycin Hydrochloride in Selective Media: Innovations and

  2026-06-19

  Explore the advanced use of Vancomycin hydrochloride as a glycopeptide antibacterial agent in selective media and resistance assays. This article offers an in-depth analysis of innovative methodologies, with a focus on Moraxella recovery and the compound's role in shaping microbiological research.

• PNU 74654: Reliable Wnt Signaling Inhibition for Cell Assays

  2026-06-18

  This in-depth article explores how PNU 74654 (SKU B7422) addresses persistent laboratory challenges in Wnt/β-catenin pathway research, particularly in cell viability and differentiation assays. Integrating real-world experimental scenarios, the piece clarifies protocol parameters, quality drivers, and selection criteria, ensuring researchers can achieve reproducible and insightful results with confidence.

• Alpha-Ketoglutarate in Metabolic Reprogramming Research

  2026-06-18

  Alpha-ketoglutarate (α-KGA) is rapidly emerging as a cornerstone reagent for dissecting metabolic and immune interactions in cancer and beyond. This article delivers a practical roadmap for deploying α-KGA in metabolic reprogramming workflows, with actionable troubleshooting and protocol insights that drive robust, reproducible results.

• SCH772984 HCl: ERK1/2 Inhibitor Workflows for MAPK Pathway S

  2026-06-17

  SCH772984 HCl, a potent ERK1/2 inhibitor from APExBIO, enables precise dissection of MAPK signaling in cancer and neuroendocrine models. This article delivers actionable protocols, troubleshooting strategies, and insights for maximizing performance in BRAF- and RAS-mutant tumor research and mechanistic signaling assays.

• Structural Insights into TRPM3 Regulation by Primidone and N

  2026-06-17

  Yin et al. provide cryo-EM structures illuminating how Primidone and neurosteroids modulate the TRPM3 channel, a key player in pain and neurodevelopmental disorders. Their mechanistic findings clarify drug interactions and support the precision development of TRPM3-targeted therapies in both basic and translational neuroscience.

• Z-VDVAD-FMK: Precision Caspase-2 Inhibition for Translationa

  2026-06-16

  This thought-leadership article explores the mechanistic underpinnings and translational opportunities of Z-VDVAD-FMK, an irreversible caspase-2 inhibitor, as a pivotal tool for apoptosis pathway dissection. By integrating recent host-pathogen research, advanced apoptosis assay strategies, and practical protocol guidance, we position Z-VDVAD-FMK as an essential asset for researchers aiming to move beyond traditional cell death models and into the frontiers of antiviral and cancer research.

• Origami-Engineered KR-12 Peptides: Innovations in Antimicrob

  2026-06-16

  This article reviews the recent advances in designing and applying origami-like KR-12 antimicrobial peptides, as detailed in the reference paper, highlighting their structural innovation, antimicrobial activity, and potential for overcoming antibiotic resistance. Implications for peptide engineering and comparative insights with glycopeptide agents like vancomycin are discussed.

10322 records 6/689 page Previous Next First page 上5页 678910 下5页 Last page